APOD and acute lymphoblastic leukemia: Moreover, Apo-C1 and Apo-D levels were decreased in the overweight and obese subgroup from the ALL group in comparison with the control patients with normal weight (18.37 ± 5.59 vs. 24.31 ± 9.04 mg/dL and 3.60 ± 0.61 vs. 28.74 ± 28.90 mg/dL, respectively; p < 0.05; Table 2).